Detalhe da pesquisa
1.
PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis.
J Hepatol
; 62(1): 24-30, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25135864
2.
Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.
Gastroenterology
; 147(1): 132-142.e4, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24704719
3.
Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG study.
J Hepatol
; 61(4): 761-9, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24882048
4.
Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24.
Ann Rheum Dis
; 73(5): 831-7, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23606708
5.
Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.
Blood
; 116(3): 326-34; quiz 504-5, 2010 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-20439619
6.
Prognostic factors in patients with hepatitis C virus infection and systemic vasculitis.
Arthritis Rheum
; 63(6): 1748-57, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21400476
7.
Adherence to treatment and quality of life during hepatitis C therapy: a prospective, real-life, observational study.
Liver Int
; 31(4): 516-24, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21382162
8.
Insulin resistance impairs sustained virological response rate to pegylated interferon plus ribavirin in HIV-hepatitis C virus-coinfected patients: HOMAVIC-ANRS HC02 Study.
Antivir Ther
; 14(6): 839-45, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19812446
9.
Effect of antiviral treatment on serum markers of liver fibrosis in HIV-hepatitis C virus-coinfected patients: the Fibrovic 2 Study - ANRS HC02.
Antivir Ther
; 14(2): 211-9, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19430096
10.
HCV-associated cryoglobulinemic vasculitis: triple/dual antiviral treatment and/or rituximab? Reply to the comment by Ignatova et al.
Ann Rheum Dis
; 73(9): e59, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24969272
11.
Patient education improves adherence to peg-interferon and ribavirin in chronic genotype 2 or 3 hepatitis C virus infection: a prospective, real-life, observational study.
World J Gastroenterol
; 14(40): 6195-203, 2008 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-18985810
12.
Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study.
PLoS One
; 11(10): e0162965, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27749916
13.
Spontaneous hepatic decompensation in patients coinfected with HIV and hepatitis C virus during interferon-ribavirin combination treatment.
Clin Infect Dis
; 41(12): 1806-9, 2005 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16288408
14.
Vogt-Koyanagi-Harada disease in patients with chronic hepatitis C.
Am J Ophthalmol
; 140(5): 949-52, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16310490
15.
Treatment of hepatitis C in HIV/hepatitis C co-infected patients: what is the evidence?
Int J STD AIDS
; 16(1): 1-4, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15705263
16.
Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study.
World J Gastroenterol
; 21(18): 5647-53, 2015 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25987791
17.
Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN.
Am J Kidney Dis
; 43(4): 617-23, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15042538
18.
Phase IV study of liposomal daunorubicin (DaunoXome) in AIDS-related Kaposi sarcoma.
Am J Clin Oncol
; 25(1): 57-9, 2002 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-11823698
19.
Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.
JAMA
; 292(23): 2839-48, 2004 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15598915
20.
Causes and predictive factors of mortality in a cohort of patients with hepatitis C virus-related cryoglobulinemic vasculitis treated with antiviral therapy.
J Rheumatol
; 37(3): 615-21, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20110523